RedHill Biopharma's total assets for Q2 2025 were $18.38M, a decrease of 0.00% from the previous quarter. RDHL total liabilities were $22.79M for the fiscal quarter, a 0.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.